Season’s Greetings from Ian Lipkin and the Center for Infection & Immunity
“None of this would have been possible without your support”
Doctor Ian Lipkin covered “the greatest hits of 2016” including ME/CFS, tick-borne diseases, SARS, and tilapia in this new video from CII.
“Another disease we’ve been studying with increased vigor is known as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. And with the support of the Microbe Discovery Project as well as work that we’ve been able to do under the auspices of the NIH; with your support and the support of these various foundations and generous individuals, we’ve now collected thousands of samples. And we’re eager to begin to work on these so that we can actually dissect the causes of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and come up with real solutions for these problems.” – Dr. Ian Lipkin
On this blog, we often focus so much on the great work that CII is doing on ME/CFS that we forget about their other incredible work!
To learn more about the award and their work responding to SARS, check out the announcement from the Mailman School of Public Health.
To learn more about CII’s work related to the Zika virus, see the press page from the Mailman School of Public Health with links to over a dozen articles.
The CII team has also expanded research into tick-borne diseases. From a Fox News article on the topic:
“Lipkin’s group has collected 5,000 ticks from New York and Connecticut. With funding from the Steven and Alexandra Cohen Foundation, he has so far identified 20 new viruses in these ticks, and is exploring whether they have caused harmful infections in people, using tests that can search for a wide range of tick pathogens in a single sera sample. Eventually, Lipkin said, this process could make the tests affordable on a mass scale.” – Charles Piller
We are here to serve you
“We are your Center for Infection and Immunity and we are here to serve you, the people of the United States, and the people of the world with the best that science has to offer.” – Dr. Ian Lipkin